Get the Stockscreener App
11.27
1.58%
0.175
Instil Bio Inc stock is traded at $11.27, with a volume of 54,619.
It is up +1.58% in the last 24 hours and down -7.62% over the past month.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
See More
Previous Close:
$11.10
Open:
$11.2693
24h Volume:
54,619
Relative Volume:
0.61
Market Cap:
$76.43M
Revenue:
-
Net Income/Loss:
$-74.14M
P/E Ratio:
-0.9895
EPS:
-11.39
Net Cash Flow:
$-65.70M
1W Performance:
+3.97%
1M Performance:
-7.62%
6M Performance:
-60.57%
1Y Performance:
-43.87%
1-Day Range:
$11.13
$11.62
1-Week Range:
$10.69
$11.85
52-Week Range:
$10.69
$42.79
Instil Bio Inc Stock (TIL) Company Profile
Name
Instil Bio Inc
Sector
Industry
Phone
(972) 499-3350
Address
3963 MAPLE AVENUE, DALLAS
Compare TIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
11.27 | 75.25M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.20 | 113.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.96 | 78.69B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.23 | 52.32B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.99 | 52.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.84 | 35.52B | 447.02M | -1.18B | -906.14M | -6.1812 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Jefferies | Hold → Buy |
| Nov-04-24 | Initiated | JMP Securities | Mkt Perform |
| Apr-12-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Nov-01-22 | Downgrade | Truist | Buy → Hold |
| Aug-13-21 | Initiated | Robert W. Baird | Outperform |
| Apr-13-21 | Initiated | Cowen | Outperform |
| Apr-13-21 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-21 | Initiated | Truist | Buy |
View All
Instil Bio Inc Stock (TIL) Latest News
Insider Buy: How Instil Bio Inc stock performs after earningsChart Signals & Short-Term Trading Alerts - moha.gov.vn
Rally Mode: Why Instil Bio Inc. stock is favored by top institutionsJuly 2025 Review & High Accuracy Trade Alerts - Улправда
Support Test: Is Instil Bio Inc. stock a good choice for value investorsDividend Hike & Low Drawdown Investment Ideas - Улправда
Will Instil Bio Inc. stock see PE expansionJuly 2025 Price Swings & AI Optimized Trading Strategy Guides - Улправда
Why analysts remain bullish on Instil Bio Inc. stockWeekly Investment Recap & Free Safe Entry Trade Signal Reports - Улправда
Will Instil Bio Inc. stock benefit from green energy trendsJuly 2025 Action & Free High Accuracy Swing Entry Alerts - DonanımHaber
Aug Catalysts: Will Instil Bio Inc. stock outperform Dow Jones indexQuarterly Market Summary & Free Verified High Yield Trade Plans - DonanımHaber
Analyst Downgrade: Is Instil Bio Inc. stock a good choice for value investors2025 Price Action Summary & Weekly Sector Rotation Insights - Улправда
Is Instil Bio Inc. stock attractive for hedge fundsMarket Activity Report & AI Enhanced Trade Execution Alerts - DonanımHaber
(TIL) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Check out Instil Bio's stock price (5GT0-FF) in real time - CNBC
Is Instil Bio Inc a good long term investmentInsider Selling Patterns & Free Stock Trading Workshops - earlytimes.in
Responsive Playbooks and the TIL Inflection - news.stocktradersdaily.com
Instil Bio Inc (TIL) looking to reclaim success with recent performance - Setenews
Operating income of Instil Bio, Inc. – FWB:5GT0 - TradingView
Understanding the Setup: (TIL) and Scalable Risk - news.stocktradersdaily.com
Why Instil Bio Inc. stock is a value investor pickMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Is Instil Bio Inc. showing signs of accumulation2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Working capital per share of Instil Bio, Inc. – FWB:5GT0 - TradingView
Instil Bio, Inc. Balance Sheet – FWB:5GT0 - TradingView
Signal strength of Instil Bio Inc. stock in tech scanners2025 Year in Review & Growth Oriented Trade Recommendations - newser.com
Will Instil Bio Inc. stock maintain momentum in 2025Portfolio Gains Report & Proven Capital Preservation Methods - newser.com
How Instil Bio Inc. stock reacts to job market data2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Is Instil Bio Inc. stock attractive for long term wealth buildingJuly 2025 Patterns & Expert Curated Trade Setups - newser.com
What hedge fund activity signals for Instil Bio Inc. stockQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Citizens reiterates Market Perform rating on Instil Bio stock By Investing.com - Investing.com Australia
Applying Wyckoff theory to Instil Bio Inc. stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-19 03:08:52 - newser.com
Citizens reiterates Market Perform rating on Instil Bio stock - Investing.com
What to expect from Instil Bio Inc. in the next 30 daysJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-11-16 10:13:27 - newser.com
Applying big data sentiment scoring on Instil Bio Inc.July 2025 Fed Impact & Daily Chart Pattern Signal Reports - newser.com
Will Instil Bio Inc. stock benefit from automationIPO Watch & Advanced Swing Trade Entry Plans - newser.com
Instil Bio Inc Stock (TIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Instil Bio Inc Stock (TIL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO |
Sep 10 '25 |
Sale |
23.39 |
30,000 |
701,667 |
0 |
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):